# 2025-22960: DEA Extends Ban on Four Synthetic Drugs for More Study Time

2025-22960, Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act, is a Federal Register rule from Justice Department, Drug Enforcement Administration published 2025-12-16, effective 2025-12-12 (as of 2026-06-11).

- Canonical: https://policyrisk.com/federal-register/2025-22960
- As of: 2026-06-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-22960
- Title: Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act
- Type: Rule
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 58149
- Published: 2025-12-16
- Effective: 2025-12-12
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-11

## In one line

DEA Extends Ban on Four Synthetic Drugs for More Study Time

## Summary

The DEA is extending the temporary ban on four risky substances—4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA—keeping them in the strictest drug category (Schedule I) for another year. This means anyone making, selling, or using these chemicals faces serious legal rules and penalties until a permanent decision is made. The extension runs from December 12, 2025, to December 12, 2026, or sooner if a final rule is set.

## Abstract

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA. The schedule I status of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA is in effect through December 12, 2025. This temporary order will extend the temporary scheduling of these four substances for one year, or until the permanent scheduling action for these substances is completed, whichever occurs first. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will continue to be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA.

## Effects PRIA read

- Temporary Schedule I Status Extended One Year: cost, high. The DEA extends temporary Schedule I control of four synthetic cannabinoids — 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA — from December 12, 2025 through December 12, 2026, or until a final scheduling rule takes effect. The extension also covers their salts, isomers, and salts of…
- Businesses Making or Selling Face Continued Liability: cost, high. If you manufacture, distribute, reverse-distribute, import, or export these four substances, you remain subject to the regulatory controls and the administrative, civil, and criminal sanctions that apply to Schedule I controlled substances for the period December 12, 2025 to December 12, 2026. The…
- Researchers and Laboratories—Controls Continue: cost, medium. If you engage in research, instructional activities, or chemical analysis with these four substances, you continue to be subject to Schedule I controls and the associated administrative, civil, and criminal sanctions during the extension period (December 12, 2025 to December 12, 2026). The order co…
- Users and Possessors Remain Subject to Penalties: cost, high. If you possess or use 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, or MMB-FUBICA (including their salts and isomers), the administrative, civil, and criminal sanctions for Schedule I substances remain in effect from December 12, 2025 through December 12, 2026. The temporary order continues penalti…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-22960 on federalregister.gov](https://www.federalregister.gov/documents/2025/12/16/2025-22960/schedules-of-controlled-substances-extension-of-temporary-placement-of-4f-mdmb-butica-adb-4en-pinaca)
- [2025-22960 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-12-16/pdf/2025-22960.pdf)

## Related
- [Previous: 2025-22957, Safety Zone; Fireworks Display, Lower Mississippi River, Natchez, MS](https://policyrisk.com/federal-register/2025-22957)
- [Next: 2025-22961, 2025 Quarterly Listings; Second Quarter; Safety Zones, Security Zones, and Spec…](https://policyrisk.com/federal-register/2025-22961)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-22960 (as of 2026-06-11).
